These findings indicate that the inhibition of syndecan-1 shedding and VEGF-VEGFR-2 stimulation are novel targets in preventing or managing AKI, since serum blood urea nitrogen (BUN), creatinine, and urine output are delayed signs of deteriorating kidney function [8]. Here, SDC1 is linked to acute kidney injury.